Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | AGXT | P21549 | 2/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | MMP13 | P45452 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL3072058 | 0.96 | CTBP2 (0.59) | CTBP2IDO1AGXTMTNR1AMTNR1B | |
| SCHEMBL4071390 | 0.87 | CTBP2 (0.64) | CTBP2IDO1AGXTMTNR1AMTNR1B | |
| SCHEMBL2209808 | 0.86 | CTBP2 (0.56) | CTBP2MTNR1AMTNR1BCYP1A2ALDH1A1 | |
| SCHEMBL15513856 | 0.85 | CTBP2 (0.62) | CTBP2IDO1AGXTMTNR1AMTNR1B | |
| SCHEMBL229067 | 0.85 | PTGS1 (0.67) | CTBP2IDO1AGXTCYP1A2ALDH1A1 | |
| SCHEMBL29824310 | 0.85 | PTGS1 (0.67) | CTBP2IDO1AGXTCYP1A2ALDH1A1 | |
| SCHEMBL4957554 | 0.85 | CTBP2 (0.57) | CTBP2IDO1AGXTMTNR1AMTNR1B | |
| SCHEMBL4684338 | 0.84 | CTBP2 (0.60) | CTBP2IDO1AGXTMTNR1AMTNR1B | |
| SCHEMBL378705 | 0.84 | SMN1; SMN2 (0.61) | CTBP2MTNR1AMTNR1BCYP1A2ALDH1A1 | |
| SCHEMBL694402 | 0.84 | CYP3A4 (0.58) | CTBP2ALDH1A1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| CN-106518635-A | Synthesis method for 3-methoxypropiophenone | 三峡大学 | 2017-03-22 | — | — | CN | claimed |
| WO-2016202808-A2 | NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES | AZAD PHARMACEUTICAL INGREDIENTS AG (CH) | 2016-12-22 | — | — | WO | claimed |
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | claimed |
| EP-2519100-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | Mapi Pharma Limited (IL) | 2012-11-07 | — | — | EP | claimed |
| WO-2011080736-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | MAPI PHARMA HK LIMITED (CN) | 2011-07-07 | — | — | WO | claimed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | claimed |
| CN-101494999-A | Method for using organic compound | GIVAUDAN SA (CH) | 2009-07-29 | — | — | CN | claimed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | claimed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | claimed |
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | GLENMARK SPECIALITY S.A. (CH) | 2026-03-17 | — | — | US | disclosed |
| US-20250388565-A1 | ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2025-12-25 | — | — | US | disclosed |
| CN-119176758-B | Method for preparing tapentadol or pharmaceutically acceptable salt thereof by immobilized catalysis | 苏州盛迪亚生物医药有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-4187313-A | HYPOTENSIVE AGENTS, BRADYCARDIC AGENTS | CIBA-GEIGY CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
| EP-0003359-A1 | Specific optical isomers of 2-aminoethyl-1,4-benzodioxanes, process for their preparation and their pharmaceutical compositions | CIBA-GEIGY AG (CH) | 1979-08-08 | — | — | EP | disclosed |
| US-4139425-A | CONTAINING AS A BRIGHTENER THE REACTION PRODUCT OF AN UNSATURATED NITROGEN HETEROCYCLIC CPD. WITH FORMALDEHYDE AND AN UNSATD ALDEHYDE | R. O. HULL & COMPANY, INC. (US) | 1979-02-13 | — | — | US | disclosed |
| US-3987200-A | INOTROPIC AGENTS, 3,4-DIHYDROXY-PHENYL-ALKYL PHENETHYLAMINE | ELI LILLY AND COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | PTK2B, MAP3K10, MAP3K20 | CTBP2 2811/4885IDO1 1745/4885AGXT 4690/4885 |
| US-20090311403-A1 | Method of Using Organic Compounds | MGLL, GK, LIPC | CTBP2 1977/4885IDO1 3181/4885AGXT 247/4885 |
| US-20250388565-A1 | ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF | ESRRA, ESRRB, ESR2 | CTBP2 2523/4885IDO1 3040/4885AGXT 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.